Given its demonstrated dysregulation across various autoimmune conditions,18 elucidating its temporal kinetics is pivotal to portray IFN score as a dynamic biomarker, revealing SSc disease flares and progression, or potentially establishing this biomarker as a stable pathogenetic signature, akin to antibody profiles. This evidence concerns the gene IFNA1 and systemic sclerosis.